Healthcare Huddle

Bridging the clinical trenches and the boardroom. Trusted by 30k+ health professionals for expert takes on business, policy, and tech that impact medicine.

Connect

Latest Posts

Feb 13, 2025

Premium

Amazon RxPass: Does a $5 Drug Subscription Improve Adherence?

Inefficiency Insights #67

Jared Dashevsky, MD

Feb 06, 2025

Premium

Can Text Reminders Fix Medication Adherence? A New Study Says No—But AI Might

Inefficiency Insights #66

Jared Dashevsky, MD

Feb 02, 2025

The 340B Drug Program: How Hospitals Profit While Patients Pay

Huddle #Trends

Jared Dashevsky, MD

Amazon RxPass: Does a $5 Drug Subscription Improve Adherence?

Inefficiency Insights #67

Jared Dashevsky, MD

Feb 06, 2025

Premium

Can Text Reminders Fix Medication Adherence? A New Study Says No—But AI Might

Inefficiency Insights #66

Jared Dashevsky, MD

Feb 02, 2025

The 340B Drug Program: How Hospitals Profit While Patients Pay

Huddle #Trends

Jared Dashevsky, MD

Jan 19, 2025

CMS Reveals 15 Drugs for Medicare Negotiation, Including Ozempic

Jared Dashevsky, MD

Jan 12, 2025

Humira Biosimilars: Market Impact, Cost Savings, and Future Trends

Jared Dashevsky, MD

Dec 08, 2024

Cost Plus Drugs Partnerships: Cutting Drug Costs for Health Systems

Jared Dashevsky, MD

Nov 14, 2024

Premium

6 Practical Ways to Save on High U.S. Prescription Drug Costs

Inefficiency Insights #57

Jared Dashevsky, MD

Oct 27, 2024

Curing Hepatitis C: The Netflix Model Explained

Jared Dashevsky, MD

Sep 08, 2024

Why Are U.S. Drug Prices So High? Solutions for Lowering Costs

Huddle #Trends

Jared Dashevsky, MD

Aug 18, 2024

CMS Negotiates Drug Prices: The Not-so-Clear Impact on Medicare Spending

Jared Dashevsky, MD

Feb 04, 2024

A Comprehensive Analysis of Mark Cuban's Cost Plus Drugs Company

Huddle+ | Huddle #Trends

Jared Dashevsky, MD

Jan 28, 2024

The Rise of Humira Biosimilars and the Battle for Market Share

Jared Dashevsky, MD

First Back

1 2 3 4

Next Last

Healthcare Huddle

Latest Posts

Amazon RxPass: Does a $5 Drug Subscription Improve Adherence?

Can Text Reminders Fix Medication Adherence? A New Study Says No—But AI Might

The 340B Drug Program: How Hospitals Profit While Patients Pay

Archive

Amazon RxPass: Does a $5 Drug Subscription Improve Adherence?

Can Text Reminders Fix Medication Adherence? A New Study Says No—But AI Might

The 340B Drug Program: How Hospitals Profit While Patients Pay

CMS Reveals 15 Drugs for Medicare Negotiation, Including Ozempic

Humira Biosimilars: Market Impact, Cost Savings, and Future Trends

Cost Plus Drugs Partnerships: Cutting Drug Costs for Health Systems

6 Practical Ways to Save on High U.S. Prescription Drug Costs

Curing Hepatitis C: The Netflix Model Explained

Why Are U.S. Drug Prices So High? Solutions for Lowering Costs

CMS Negotiates Drug Prices: The Not-so-Clear Impact on Medicare Spending

A Comprehensive Analysis of Mark Cuban's Cost Plus Drugs Company

The Rise of Humira Biosimilars and the Battle for Market Share